# Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy

> **NCT05756426** · — · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 250 (estimated)

## Conditions studied

- Hemorrhage
- Hemodynamic Instability

## Interventions

- **OTHER:** Prospective

## Key facts

- **NCT ID:** NCT05756426
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-13
- **Primary completion:** 2028-01-30
- **Final completion:** 2029-01-30
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05756426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05756426, "Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05756426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*